| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Respiratory Care, Massachusetts General Hospital, and Harvard Medical School, Boston
Background: Medication nebulizers are commonly used to delivery aerosolized medications to patients with respiratory disease. We evaluated output and respirable aerosol available to the patient (inhaled mass) for 17 medication nebulizers using a spontaneous breathing lung model.
Methods: Three nebulizer fill volumes (3, 4, and 5 mL containing 2.5 mg of albuterol) and 3 oxygen flows (6, 8, and 10 L/min) were evaluated using the 17 nebulizers. A cotton plug at the nebulizer mouthpiece was used to trap aerosol during simulated spontaneous breathing. Following each trial, the amount of albuterol remaining in the nebulizer and the amount deposited in the cotton plug were determined spectrophotometrically. Aerosol particle size was determined using an 11-stage cascade impactor.
Results: Increasing fill volume decreased the amount of albuterol trapped in the dead volume (p<0.001) and increased the amount delivered to the patient (p<0.001). Increasing flow increased the mass output of particles in the respirable range of 1 to 5 µm (p=0.004), but the respirable mass delivered to the patient was affected to a greater extent by nebulizer brand (p<0.001) than flow. Although 2.5 mg of albuterol was placed into the nebulizers, less than 0.5 mg in the respirable range of 1 to 5 µm was delivered to the mouthpiece.
Conclusions: The performance of medication nebulizers is affected by fill volume, flow, and nebulizer brand. When they are used for research applications, the nebulizer characteristics must be evaluated and reported for the conditions used in the investigation.
Key Words: aerosol therapy • inhaled bronchodilator administration • nebulizers
Submitted on October 20, 1995
Accepted on February 26, 1996
This article has been cited by other articles:
|
|
 |
|
  K. Blake, R. Madabushi, H. Derendorf, and J. Lima Population Pharmacodynamic Model of Bronchodilator Response to Inhaled Albuterol in Children and Adults With Asthma Chest, November 1, 2008; 134(5): 981 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Shirk, K. R. Donahue, and J. Shirvani Unlabeled uses of nebulized medications. Am. J. Health Syst. Pharm., September 15, 2006; 63(18): 1704 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wong-Beringer, M. P. Lambros, P. M. Beringer, and D. L. Johnson Suitability of Caspofungin for Aerosol Delivery: Physicochemical Profiling and Nebulizer Choice Chest, November 1, 2005; 128(5): 3711 - 3716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Rubin What Does It Mean When a Patient Says, "My Asthma Medication Is Not Working?" Chest, September 1, 2004; 126(3): 972 - 981. [Full Text] [PDF]
|
|
|
|
 |
|
 I Amirav, I Balanov, M Gorenberg, D Groshar, and A S Luder Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears! Arch. Dis. Child., August 1, 2003; 88(8): 719 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Amirav, I. Balanov, M. Gorenberg, A. S. Luder, M. T. Newhouse, and D. Groshar {beta}-Agonist Aerosol Distribution in Respiratory Syncytial Virus Bronchiolitis in Infants J. Nucl. Med., April 1, 2002; 43(4): 487 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. FAUROUX, E. ITTI, J. PIGEOT, D. ISABEY, M. MEIGNAN, G. FERRY, F. LOFASO, J.-M. WILLEMOT, A. CLÉMENT, and A. HARF Optimization of Aerosol Deposition by Pressure Support in Children with Cystic Fibrosis . An Experimental and Clinical Study Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2265 - 2271. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Ploin, F. R. Chapuis, D. Stamm, J. Robert, L. David, P. G. Chatelain, G. Dutau, and D. Floret High-Dose Albuterol by Metered-Dose Inhaler Plus a Spacer Device Versus Nebulization in Preschool Children With Recurrent Wheezing: A Double-Blind, Randomized Equivalence Trial Pediatrics, August 1, 2000; 106(2): 311 - 317. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Jantz and N. A. Collop Bronchodilator Aerosol Delivery in Mechanical Ventilation: Jantz MA, Collop NA Bronchodilator Aerosol Delivery in Mechanical Ventilation Intensive Care Med 1999,14 166-183 J Intensive Care Med, July 1, 1999; 14(4): 166 - 183. [PDF]
|
|
|
|
|
|
D. R. Hess, F. L. Acosta, R. H. Ritz, R. M. Kacmarek, and C. A. Camargo Jr The Effect of Heliox on Nebulizer Function Using a {beta}-Agonist Bronchodilator Chest, January 1, 1999; 115(1): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Johnson, S. Jacobson, P. C. Edney, P. Hadfield, M. E. Mundy, and S. Schuh A Comparison of Nebulized Budesonide, Intramuscular Dexamethasone, and Placebo for Moderately Severe Croup N. Engl. J. Med., August 20, 1998; 339(8): 498 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Parrott Metered Dose Inhaler and Nebulizer Use in Asthmatic Patients Journal of Pharmacy Practice, June 1, 1997; 10(3): 203 - 210. [Abstract] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
